Overview Financials News + Filings Key Docs Ownership Insiders
|
|
Vera Therapeutics, Inc.
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| | 10-K | 10-K | S-1 |
| Revenues | 100.0% | 100.0% | |
| Cost of goods sold | 0.0% | 0.0% | |
| Gross profit | 100.0% | 100.0% | |
| Research and development | 65.0% | 86.1% | |
| General and administrative | 34.5% | 7.7% | |
| EBITDA | -99.0% | -93.3% | |
| Depreciation | 0.5% | 0.5% | |
| EBIT | -99.5% | -93.8% | |
| Pre-tax income | -94.3% | -101.8% | |
| Income taxes | 0.0% | 0.0% | |
| Net income | -94.3% | -101.8% | |
|